A citation-based method for searching scientific literature

B A Alman, C Li, M E Pajerski, S Diaz-Cano, H J Wolfe. Am J Pathol 1997
Times Cited: 234







List of co-cited articles
606 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.
Alexander J F Lazar, Daniel Tuvin, Shohrae Hajibashi, Sultan Habeeb, Svetlana Bolshakov, Empar Mayordomo-Aranda, Carla L Warneke, Dolores Lopez-Terrada, Raphael E Pollock, Dina Lev. Am J Pathol 2008
278
42

Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).
S Tejpar, F Nollet, C Li, J S Wunder, G Michils, P dal Cin, E Van Cutsem, B Bapat, F van Roy, J J Cassiman,[...]. Oncogene 1999
230
34

Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment.
Marco Fiore, Françoise Rimareix, Luigi Mariani, Julien Domont, Paola Collini, Cecile Le Péchoux, Paolo G Casali, Axel Le Cesne, Alessandro Gronchi, Sylvie Bonvalot. Ann Surg Oncol 2009
236
26

Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation.
Sébastien Salas, Armelle Dufresne, Binh Bui, Jean-Yves Blay, Philippe Terrier, Dominique Ranchere-Vince, Sylvie Bonvalot, Eberhard Stoeckle, Louis Guillou, Axel Le Cesne,[...]. J Clin Oncol 2011
213
22


High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.
J Dômont, S Salas, L Lacroix, V Brouste, P Saulnier, P Terrier, D Ranchère, A Neuville, A Leroux, L Guillou,[...]. Br J Cancer 2010
91
23

The enigma of desmoid tumors.
J J Lewis, P J Boland, D H Leung, J M Woodruff, M F Brennan. Ann Surg 1999
225
20

Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).
Michael C Heinrich, Grant A McArthur, George D Demetri, Heikki Joensuu, Petri Bono, Richard Herrmann, Hal Hirte, Sara Cresta, D Bradley Koslin, Christopher L Corless,[...]. J Clin Oncol 2006
217
20

Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution.
A Gronchi, P G Casali, L Mariani, S Lo Vullo, M Colecchia, L Lozza, R Bertulli, M Fiore, P Olmi, M Santinami,[...]. J Clin Oncol 2003
231
20

Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor).
Veridiana Pires de Camargo, Mary L Keohan, David R D'Adamo, Cristina R Antonescu, Murray F Brennan, Samuel Singer, Linda S Ahn, Robert G Maki. Cancer 2010
99
20

beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds.
Sophia S Cheon, Alexander Y L Cheah, Stefanie Turley, Puviindran Nadesan, Raymond Poon, Hans Clevers, Benjamin A Alman. Proc Natl Acad Sci U S A 2002
244
20



Optimizing treatment of desmoid tumors.
Dina Lev, Dhanasekaran Kotilingam, Caimiao Wei, Matthew T Ballo, Gunar K Zagars, Peter W T Pisters, Alexander A Lazar, Shreyaskumar R Patel, Robert S Benjamin, Raphael E Pollock. J Clin Oncol 2007
177
17

Activity of Sorafenib against desmoid tumor/deep fibromatosis.
Mrinal M Gounder, Robert A Lefkowitz, Mary Louise Keohan, David R D'Adamo, Meera Hameed, Cristina R Antonescu, Samuel Singer, Katherine Stout, Linda Ahn, Robert G Maki. Clin Cancer Res 2011
161
17

Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions.
Baishali Bhattacharya, Harrison Parry Dilworth, Christine Iacobuzio-Donahue, Francesca Ricci, Kristin Weber, Mary A Furlong, Cyril Fisher, Elizabeth Montgomery. Am J Surg Pathol 2005
173
17

CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
Chiara Colombo, Rosalba Miceli, Alexander J Lazar, Federica Perrone, Raphael E Pollock, Axel Le Cesne, Henk H Hartgrink, Anne-Marie Cleton-Jansen, Julien Domont, Judith V M G Bovée,[...]. Cancer 2013
112
17

High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.
Anika Hansmann, Claudia Adolph, Tilmann Vogel, Andreas Unger, Gabriela Moeslein. Cancer 2004
235
15

Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial.
Rashmi Chugh, J Kyle Wathen, Shreyaskumar R Patel, Robert G Maki, Paul A Meyers, Scott M Schuetze, Dennis A Priebat, Dafydd G Thomas, Jon A Jacobson, Brian L Samuels,[...]. Clin Cancer Res 2010
133
15

Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients.
S Bonvalot, H Eldweny, V Haddad, F Rimareix, G Missenard, O Oberlin, D Vanel, P Terrier, J Y Blay, A Le Cesne,[...]. Eur J Surg Oncol 2008
177
15


CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics.
Sophie Le Guellec, Isabelle Soubeyran, Philippe Rochaix, Thomas Filleron, Agnès Neuville, Isabelle Hostein, Jean-Michel Coindre. Mod Pathol 2012
81
17

The pharmacological treatment of aggressive fibromatosis: a systematic review.
J Janinis, M Patriki, L Vini, G Aravantinos, J S Whelan. Ann Oncol 2003
201
13

Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.
Sébastien Salas, Frederic Chibon, Tetsuro Noguchi, Philippe Terrier, Dominique Ranchere-Vince, Pauline Lagarde, Jean Benard, Sébastien Forget, Camille Blanchard, Julien Dômont,[...]. Genes Chromosomes Cancer 2010
71
18

Desmoid tumours in familial adenomatous polyposis.
A K Gurbuz, F M Giardiello, G M Petersen, A J Krush, G J Offerhaus, S V Booker, M C Kerr, S R Hamilton. Gut 1994
237
13

A prognostic nomogram for prediction of recurrence in desmoid fibromatosis.
Aimeé M Crago, Brian Denton, Sébastien Salas, Armelle Dufresne, James J Mezhir, Meera Hameed, Mithat Gonen, Samuel Singer, Murray F Brennan. Ann Surg 2013
134
13

Extremity and trunk desmoid tumors: a multifactorial analysis of outcome.
N B Merchant, J J Lewis, J M Woodruff, D H Leung, M F Brennan. Cancer 1999
224
12

Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Maria Fernanda C Amary, Patrick Pauwels, Els Meulemans, Guido M Roemen, Lily Islam, Bernadine Idowu, Konstantinos Bousdras, Timothy C Diss, Paul O'Donnell, Adrienne M Flanagan. Am J Surg Pathol 2007
63
19

Long-term outcomes for desmoid tumors treated with radiation therapy.
B Ashleigh Guadagnolo, Gunar K Zagars, Matthew T Ballo. Int J Radiat Oncol Biol Phys 2008
92
13

Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG).
D Garbay, A Le Cesne, N Penel, C Chevreau, P Marec-Berard, J-Y Blay, M Debled, N Isambert, A Thyss, E Bompas,[...]. Ann Oncol 2012
90
13

Estrogen receptor-beta expression in extraabdominal fibromatoses: an analysis of 40 cases.
Andrea T Deyrup, Maria Tretiakova, Anthony G Montag. Cancer 2006
80
13

Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.
A Azzarelli, A Gronchi, R Bertulli, J D Tesoro, D Baratti, E Pennacchioli, P Dileo, A Rasponi, A Ferrari, S Pilotti,[...]. Cancer 2001
142
11

Surgical management of intra-abdominal desmoid tumours.
A J Smith, J J Lewis, N B Merchant, D H Leung, J M Woodruff, M F Brennan. Br J Surg 2000
123
11


Individualizing management of aggressive fibromatoses.
M A Spear, L C Jennings, H J Mankin, I J Spiro, D S Springfield, M C Gebhardt, A E Rosenberg, J T Efird, H D Suit. Int J Radiat Oncol Biol Phys 1998
198
10


Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis.
Makoto Gega, Hidenori Yanagi, Reigetsu Yoshikawa, Masafumi Noda, Hiroki Ikeuchi, Kiyoshi Tsukamoto, Tsutomu Oshima, Yoshinori Fujiwara, Nobuhisa Gondo, Kazuo Tamura,[...]. J Clin Oncol 2006
116
10

Aggressive fibromatosis of the abdominal wall, limbs and limb girdles.
S R Phillips, R A'Hern, J M Thomas. Br J Surg 2004
62
16


Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up.
N Penel, A Le Cesne, B N Bui, D Perol, E G Brain, I Ray-Coquard, C Guillemet, C Chevreau, D Cupissol, S Chabaud,[...]. Ann Oncol 2011
126
10

Desmoid tumours.
C J Shields, D C Winter, W O Kirwan, H P Redmond. Eur J Surg Oncol 2001
160
9

Desmoid tumors: need for an individualized approach.
Eelco de Bree, Ronald Keus, John Melissas, Dimitris Tsiftsis, Frits van Coevorden. Expert Rev Anticancer Ther 2009
70
12

Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis.
Anastasia Constantinidou, Robin L Jones, Michelle Scurr, Omar Al-Muderis, Ian Judson. Eur J Cancer 2009
68
13

Nuclear beta-catenin in mesenchymal tumors.
Tony L Ng, Allen M Gown, Todd S Barry, Maggie C U Cheang, Andy K W Chan, Dmitry A Turbin, Forrest D Hsu, Robert B West, Torsten O Nielsen. Mod Pathol 2005
182
9

Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
Stephen X Skapek, William S Ferguson, Linda Granowetter, Meenakshi Devidas, Antonio R Perez-Atayde, Louis P Dehner, Fredric A Hoffer, Roseanne Speights, Mark C Gebhardt, Gary V Dahl,[...]. J Clin Oncol 2007
115
9

Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis.
Danique L M van Broekhoven, Cornelis Verhoef, Dirk J Grünhagen, Joost M H H van Gorp, Michael A den Bakker, John W J Hinrichs, Carmen M A de Voijs, Thijs van Dalen. Ann Surg Oncol 2015
70
12

Desmoid tumor: a disease opportune for molecular insights.
D Kotiligam, A J F Lazar, R E Pollock, D Lev. Histol Histopathol 2008
74
10

The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network.
Brigitta G Baumert, Martin O Spahr, Arthur Von Hochstetter, Sylvie Beauvois, Christine Landmann, Katrin Fridrich, Salvador Villà, Michael J Kirschner, Guy Storme, Peter Thum,[...]. Radiat Oncol 2007
62
12

Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor).
R Poon, R Smits, C Li, S Jagmohan-Changur, M Kong, S Cheon, C Yu, R Fodde, B A Alman. Oncogene 2001
75
10

Desmoid tumors: clinical features and treatment options for advanced disease.
Bernd Kasper, Philipp Ströbel, Peter Hohenberger. Oncologist 2011
134
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.